Citadel Advisors
ADN

Citadel Advisors’s Advent Technologies ADN Stock Holding History

Citadel Advisors’s Portfolio ADN Stock Details ADN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-252
Closed -$1.26K – 14381
2024
Q4 		$1.26K Buy
+252
New +$1.04K ﹤0.01% 14208
2024
Q2 		– Sell
-293
Closed -$1.58K – 14145
2024
Q1 		$1.58K Sell
293
-577
-66% -$3.16K ﹤0.01% 14111
2023
Q4 		$5.82K Buy
870
+473
+119% +$5.45K ﹤0.01% 13402
2023
Q3 		$4.66K Buy
397
+47
+13% +$925 ﹤0.01% 13468
2023
Q2 		$6.18K Sell
350
-253
-42% -$6.11K ﹤0.01% 13445
2023
Q1 		$19.2K Sell
603
-1,220
-67% -$61.6K ﹤0.01% 13095
2022
Q4 		$99K Buy
1,823
+226
+14% +$14K ﹤0.01% 11238
2022
Q3 		$147K Buy
1,597
+1,004
+169% +$89.5K ﹤0.01% 10719
2022
Q2 		$45K Buy
593
+83
+16% +$5.01K ﹤0.01% 11998
2022
Q1 		$36K Buy
+510
New +$57.8K ﹤0.01% 12998
2021
Q4 		– Sell
-1,220
Closed -$318K – 13705
2021
Q3 		$318K Sell
1,220
-1,313
-52% -$319K ﹤0.01% 10935
2021
Q2 		$733K Buy
+2,533
New +$842K ﹤0.01% 9146

Other funds holding ADN

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Citadel Advisors's ADN Position: Q3 2025 in Review

Citadel Advisors sold out of Advent Technologies (ADN) in Q3 2025, closing a stake of 12,040 shares — an estimated $25.3K sold.

Citadel Advisors first reported a position in ADN in Q1 2021 and held it in 11 quarters. The position peaked at $816K in Q3 2021. 18 funds tracked by Wall St. Rank hold ADN as of Q3 2025.

  • Citadel Advisors reported no remaining Advent Technologies position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 12,040 Advent Technologies shares in Q3 2025, an estimated $25.3K.
  • Citadel Advisors first reported a position in Advent Technologies in Q1 2021 and held it in 11 quarters.
  • Citadel Advisors's Advent Technologies position peaked at $816K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Advent Technologies as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.